{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:47:59Z","timestamp":1791913679346,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canrad.2026.104863","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:48:16Z","timestamp":1790182096000},"page":"104863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modern adjuvant radiotherapy for breast adenoid cystic carcinoma: Clinical outcomes across normofractionated and hypofractionated schedules"],"prefix":"10.1016","volume":"30","author":[{"given":"S\u00e9bastien","family":"Laroze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Loap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2026.104863_bib0005","first-page":"209","article-title":"Global Cancer Statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2026.104863_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2025.103792","article-title":"Mammary mucoepidermoid carcinomas: a population-based analysis","volume":"40","author":"Loap","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2026.104863_bib0015","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/bcr2613","article-title":"Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study","volume":"12","author":"Ghabach","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canrad.2026.104863_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.breast.2022.09.003","article-title":"Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast","volume":"66","author":"Zhang","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.canrad.2026.104863_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.103878","article-title":"Personalized treatment strategies for breast adenoid cystic carcinoma: a machine learning approach","volume":"79","author":"Alshwayyat","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.canrad.2026.104863_bib0030","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.ijrobp.2010.12.008","article-title":"Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study","volume":"82","author":"Khanfir","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104863_bib0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jso.21638","article-title":"Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast","volume":"102","author":"Coates","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0040","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0045","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0050","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2026.104863_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.canrad.2025.104767","article-title":"Radiotherapy of breast cancer: 2025 update","volume":"29","author":"Ghannam","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104863_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.canrad.2025.104688","article-title":"Breast cancer tumour board: which patients are eligible for radiotherapy de-escalation or omission?","volume":"29","author":"Hibon","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104863_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canrad.2025.104612","article-title":"Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: excellent early tolerance or delayed skin reactions? Real life experience","volume":"29","author":"Bouziane","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104863_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.789079","article-title":"Biological rationale and clinical evidence of carbon ion radiation therapy for adenoid cystic carcinoma: a narrative review","volume":"11","author":"Loap","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00066-021-01777-2","article-title":"The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice","volume":"197","author":"Loap","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2026.104863_bib0080","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.12.006","article-title":"The limits of the linear quadratic (LQ) model for late cardiotoxicity prediction: example of hypofractionated rotational intensity modulated radiation therapy (IMRT) for breast cancer","volume":"106","author":"Loap","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104863_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clon.2012.07.012","article-title":"Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart","volume":"25","author":"Appelt","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2026.104863_bib0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG Oncology\/RTOG 1014 phase 2 clinical trial","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103574","article-title":"Hadrontherapy techniques for breast cancer","volume":"169","author":"Loap","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2026.104863_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.738320","article-title":"Hadrontherapy for thymic epithelial tumors: implementation in clinical practice","volume":"11","author":"Loap","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.annonc.2024.02.002","article-title":"Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522","volume":"35","author":"Pusztai","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0110","article-title":"Tolerance of concurrent adjuvant radiotherapy and pembrolizumab for triple negative breast cancer: real life experience","volume":"9","author":"Tison","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103121","article-title":"Cardiotoxicity in breast cancer patients treated with radiation therapy: from evidences to controversies","volume":"156","author":"Loap","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2026.104863_bib0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/0284186X.2023.2177976","article-title":"Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT)","volume":"62","author":"Loap","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2022.10.003","article-title":"Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: a PTCOG Lymphoma Subcommittee report and recommendations","volume":"177","author":"Patel","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2026.104863_bib0130","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.canrad.2020.04.012","article-title":"Evaluation of a delineation software for cardiac atlas-based autosegmentation: an example of the use of artificial intelligence in modern radiotherapy","volume":"24","author":"Loap","year":"2020","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.canrad.2026.104863_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canrad.2020.05.016","article-title":"Evaluating cardiac substructure exposure in breast rotational intensity modulated radiation therapy: effects of cancer laterality, fractionation and deep inspiration breath-hold","volume":"25","author":"Loap","year":"2021","journal-title":"Cancer Radiother"},{"issue":"6","key":"10.1016\/j.canrad.2026.104863_bib0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.prro.2022.02.004","article-title":"Development of simplified auto-segmentable functional cardiac atlas","volume":"12","author":"Loap","year":"2022","journal-title":"Pract Radiat Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:03:27Z","timestamp":1791911007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321826000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1278321826000661"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104863","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern adjuvant radiotherapy for breast adenoid cystic carcinoma: Clinical outcomes across normofractionated and hypofractionated schedules","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104863"}}